Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging

References

• Yano S, Zhang Y, Miwa S, Tome Y, Hiroshima Y, Uehara F, Yamamoto M, Suetsugu A, Kishimoto H, Tazawa H, et al. Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness. Cell Cycle 2014; 13:2110-9; PMID:24811200; http://dx.doi.org/10.4161/cc.29156
   PubMed Web of Science ®Google Scholar
• Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H, Kashiwagi S, Fukami K, Miyata T, Miyoshi H, et al. Visualizing spatiotemporal dynamics of multicellular cell cycle progression. Cell 2008; 132:487-98; PMID:18267078; http://dx.doi.org/10.1016/j.cell.2007.12.033
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang N, Zhao M, Hoffman RM. Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the Lewis lung carcinoma in nude mice. Oncotarget 2015; 6:14625-31; PMID:25714030; http://dx.doi.org/10.18632/oncotarget.3342
   PubMed Web of Science ®Google Scholar
• Hoffman RM, editor. Bacterial Therapy of Cancer: Methods and Protocols. Methods in Molecular Biology 1409. Walker John M, series ed. Humana Press (Springer Science + Business Media New York), 2016
   Google Scholar
• Zhao M, Yang M, Li XM, Jiang P, Baranov E, Li S, Xu M, Penman S, Hoffman RM. Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. Proc Natl Acad Sci USA 2005; 102:755-60; PMID:15644448; http://dx.doi.org/10.1073/pnas.0408422102
   PubMed Web of Science ®Google Scholar
• Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci USA 2007; 104:10170-4; PMID:17548809; http://dx.doi.org/10.1073/pnas.0703867104
   PubMed Web of Science ®Google Scholar
• Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z, Hoffman RM. Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 2006; 66:7647-52; PMID:16885365; http://dx.doi.org/10.1158/0008-5472.CAN-06-0716
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tome Y, Suetsugu A, Zhang L, Zhang N, Hoffman RM, Zhao M. Determination of the optimal route of administration of Salmonella typhimurium A1-R to target breast cancer in nude mice. Anticancer Res 2012; 32:2501-8; PMID:22753706
   PubMed Web of Science ®Google Scholar
• Zhang Y, Miwa S, Zhang N, Hoffman RM, Zhao M. Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis. Oncotarget 2015; 6:2615-22; PMID:25575815; http://dx.doi.org/10.18632/oncotarget.2811
   PubMed Web of Science ®Google Scholar
• Uchugonova A, Zhao M, Zhang Y, Weinigel M, König K, Hoffman RM. Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice. Anticancer Res 2012; 32:4331-7; PMID:23060555
   PubMed Web of Science ®Google Scholar
• Liu F, Zhang L, Hoffman RM, Zhao M. Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity. Cell Cycle 2010; 9:4518-24; PMID:21135579; http://dx.doi.org/10.4161/cc.9.22.13744
   PubMed Web of Science ®Google Scholar
• Nagakura C, Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M, Hoffman RM. Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. Anticancer Res 2009; 29:1873-8; PMID:19528442
   PubMed Web of Science ®Google Scholar
• Yam C, Zhao M, Hayashi K, Ma H, Kishimoto H, McElroy M, Bouvet M, Hoffman RM. Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 2010; 164:248-55; PMID:19766244; http://dx.doi.org/10.1016/j.jss.2009.02.023
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhao M, Zhang Y, Maawy A, Hassanein MK, Uehara F, Miwa S, Yano S, Momiyama M, Suetsugu A, et al. Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells. Cell Cycle 2013; 12:2774-80; PMID:23966167; http://dx.doi.org/10.4161/cc.25872
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MH, Fleming JB, Uehara F, Miwa S, Yano S, Momiyama M, et al. Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). J Cell Biochem 2014; 115:1254-61; PMID:24435915; http://dx.doi.org/10.1002/jcb.24769
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhang Y, Murakami T, Maawy AA, Miwa S, Yamamoto M, Yano S, Sato S, Momiyama M, Mori R, et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograph (PDOX) and cell line mouse models. Oncotarget 2014; 5:12346-57; PMID:25402324; http://dx.doi.org/10.18632/oncotarget.2641
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Miwa S, Zhang Y, Hiroshima Y, Yano S, Uehara F, Yamamoto M, Toneri M, Bouvet M, Matsubara H, et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R on nude mouse models of metastatic and disseminated human ovarian cancer. J Cell Biochem 2014; 115:1996-2003; PMID:24924355
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Miwa S, Zhang Y, Zhao M, Yano S, Uehara F, Yamamoto M, Hiroshima Y, Toneri M, Bouvet M, et al. Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice. Oncotarget 2015; 6:11369-77; PMID:25957417; http://dx.doi.org/10.18632/oncotarget.3607
   PubMed Web of Science ®Google Scholar
• Yano S, Zhang Y, Zhao M, Hiroshima Y, Miwa S, Uehara F, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, et al. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy. Cell Cycle 2014; 13:3958-63; PMID:25483077; http://dx.doi.org/10.4161/15384101.2014.964115
   PubMed Web of Science ®Google Scholar
• Hiroshima Y, Zhang Y, Zhao M, Zhang N, Murakami T, Maawy A, Mii S, Uehara F, Yamamoto M, Miwa S, et al. Tumor-targeting Salmonella typhimurium A1-R in combination with Trastuzumab eradicates HER-2-positive cervical cancer cells in patient-derived mouse models. PLoS One 2015; 10:e0120358; PMID:26047477; http://dx.doi.org/10.1371/journal.pone.0120358
   PubMed Web of Science ®Google Scholar
• Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Hoffman RM. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 2009; 106:992-8; PMID:19199339; http://dx.doi.org/10.1002/jcb.22078
   PubMed Web of Science ®Google Scholar
• Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Kishimoto H, Bouvet M, Hoffman RM. Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium. Cell Cycle 2009; 8:870-5; PMID:19221501; http://dx.doi.org/10.4161/cc.8.6.7891
   PubMed Web of Science ®Google Scholar
• Miwa S, Zhang Y, Baek K-E, Uehara F, Yano S, Yamamoto M, Hiroshima Y, Matsumoto Y, Kimura H, Hayashi K, et al. Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-R. Oncotarget 2014; 5:12849-61; PMID:25528763; http://dx.doi.org/10.18632/oncotarget.2561
   PubMed Web of Science ®Google Scholar
• Murakami T, DeLong J, Eilber FC, Zhao M, Zhang Y, Zhang N, Singh A, Russell T, Deng S, Reynoso J, et al. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft PDOX model. Oncotarget, 2016; 7:12783-90.
   Google Scholar
• Kimura H, Zhang L, Zhao M, Hayashi K, Tsuchiya H, Tomita K, Bouvet M, Wessels J, Hoffman RM. Targeted therapy of spinal cord glioma with a genetically-modified Salmonella typhimurium. Cell Proliferation 2010; 43:41-48; PMID:19922490; http://dx.doi.org/10.1111/j.1365-2184.2009.00652.x
   PubMed Web of Science ®Google Scholar
• Momiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, Endo I, Hoffman RM. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 2012; 11:628-32; PMID:22274398; http://dx.doi.org/10.4161/cc.11.3.19116
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Jacobsen SJ. Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci USA 1980; 77:7306-10; PMID:6261250; http://dx.doi.org/10.1073/pnas.77.12.7306
   PubMed Web of Science ®Google Scholar
• Stern PH, Hoffman RM. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 1986; 76:629-39; PMID:3457200
   PubMed Web of Science ®Google Scholar
• Guo H, Lishko VK, Herrera H, Groce A, Kubota T, Hoffman RM. Therapeutic tumorspecific cell cycle block induced by methionine starvation in vivo. Cancer Res 1993; 53:5676-9; PMID:8242623
   PubMed Web of Science ®Google Scholar
• Yano S, Li S, Han Q, Tan Y, Bouvet M, Fujiwara T, Hoffman RM. Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity. Oncotarget 2014; 5:8729-36; PMID:25238266; http://dx.doi.org/10.18632/oncotarget.2369
   PubMed Web of Science ®Google Scholar
• Mecham JO, Rowitch D, Wallace CD, Stern PH, Hoffman RM. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 1983; 117:429-34; PMID:6661235; http://dx.doi.org/10.1016/0006-291X(83)91218-4
   PubMed Web of Science ®Google Scholar
• Tan Y, Xu M, Hoffman RM. Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells in vitro. Anticancer Res 2010; 30:1041-6; PMID:20530407
   PubMed Web of Science ®Google Scholar
• Hoffman RM. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey. Expert Opin Biol Ther 2015; 15:21-31; PMID:25439528; http://dx.doi.org/10.1517/14712598.2015.963050
   PubMed Web of Science ®Google Scholar
• Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: A molecular definition. Oncogene 2004; 23:2825-37; PMID:15077146; http://dx.doi.org/10.1038/sj.onc.1207528
   PubMed Web of Science ®Google Scholar
• Chow JPH, Poon RYC. Mitotic catastrophe. In: Greg Enders, editor. Cell cycle deregulation in cancer. Springer, New York. 2010; 79-96.
   Google Scholar
• Vakifahmetoglu H, Olsson M, Zhivotovsky B. 2008. Death through a tragedy: Mitotic catastrophe. Cell Death Differ 2008; 15:1153-62; PMID:18404154; http://dx.doi.org/10.1038/cdd.2008.47
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. How cancer could be cured by 2015. Cell Cycle 2005; 4:269-78; PMID:15655345
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Tissue-selective therapy of cancer. Br J Cancer 2003; 89:1147-51; PMID:14520435; http://dx.doi.org/10.1038/sj.bjc.6601256
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Matching targets for selective cancer therapy. Drug Discov Today 2003; 8:1104-7; PMID:14678733; http://dx.doi.org/10.1016/S1359-6446(03)02806-X
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. “Targeting the absence” and therapeutic engineering for cancer therapy. Cell Cycle 2008; 7:1307-12; PMID:18487952; http://dx.doi.org/10.4161/cc.7.10.6250
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Teratogens as anti-cancer drugs. Cell Cycle 2005; 4:1518-21; PMID:16258270; http://dx.doi.org/10.4161/cc.4.11.2208
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells. Leukemia 2001; 15:936-41; PMID:11417480; http://dx.doi.org/10.1038/sj.leu.2402127
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Target for cancer therapy: proliferating cells or stem cells. Leukemia 2006; 20:385-91; PMID:16357832; http://dx.doi.org/10.1038/sj.leu.2404075
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Cancer stem cell and cancer stemloids: from biology to therapy. Cancer Biol Ther 2007; 6:1684-90; PMID:18344680; http://dx.doi.org/10.4161/cbt.6.11.5167
   PubMed Web of Science ®Google Scholar
• Apontes P, Leontieva OV, Demidenko ZN, Li F, Blagosklonny MV. Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget 2011; 2:222-33; PMID:21447859; http://dx.doi.org/10.18632/oncotarget.248
   PubMed Web of Science ®Google Scholar
• Rao B, van Leeuwen IM, Higgins M, Campbel J, Thompson AM, Lane DP, Lain S. Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget 2010; 1:639-50; PMID:21317459; http://dx.doi.org/10.18632/oncotarget.198
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. NCI's provocative questions on cancer: some answers to ignite discussion. Oncotarget 2011; 2:1352-67; PMID:22267462; http://dx.doi.org/10.18632/oncotarget.432
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV. Antagonistic drug combinations that select against drug resistance: from bacteria to cancer. Cancer Biol Ther 2007; 6:1013-4; PMID:17646740; http://dx.doi.org/10.4161/cbt.6.7.4340
   PubMed Web of Science ®Google Scholar
• Yano S, Miwa S, Mii S, Hiroshima Y, Uehara F, Yamamoto M, Kishimoto H, Tazawa H, Bouvet M, Fujiwara T, et al. Invading cancer cells are predominantly in G0/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging. Cell Cycle 2014; 13:953-960; PMID:24552821; http://dx.doi.org/10.4161/cc.27818
   PubMed Web of Science ®Google Scholar
• Yano S, Tazawa H, Hashimoto Y, Shirakawa Y, Kuroda S, Nishizaki M, Kishimoto H, Uno F, Nagasaka T, Urata Y, et al. A genetically engineered oncolytic adenovirus decoys and lethally traps quiescent cancer stem-like cells into S/G2/M phases. Clin Cancer Res 2013; 19:6495-505; PMID:24081978; http://dx.doi.org/10.1158/1078-0432.CCR-13-0742
   PubMed Web of Science ®Google Scholar
• Wang X, Pan L, Mao N, Sun L, Qin X, Yin J. Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines. Cancer Cell Int 2013; 13:77; PMID:23899403; http://dx.doi.org/10.1186/1475-2867-13-77
   PubMed Web of Science ®Google Scholar
• Chandrasekaran B, Kute TE, Duch DS. Synchronization of cells in the S phase of the cell cycle by 3′-azido-3′-deoxythymidine: implications for cell cytotoxicity. Cancer Chemother Pharmacol 1995; 35:489-95; PMID:7882457; http://dx.doi.org/10.1007/BF00686833
   PubMed Web of Science ®Google Scholar
• Kufe DW, Egan EM, Rosowsky A, Ensminger W, Frei E 3rd. Thymidine arrest and synchrony of cellular growth in vivo. Cancer Treat Rep 1980; 64:1307-17; PMID:7471121
   PubMedGoogle Scholar
• Vogler WR, Kremer WB, Knospe WH, Omura GA, Tornyos K. Synchronization with phase-specific agents in leukemia and correlation with clinical response to chemotherapy. Cancer Treat Rep 1976; 60:1845-59; PMID:1026339
   PubMedGoogle Scholar
• Morris CM, Fitzgerald PH. An evaluation of high resolution chromosome banding of hematologic cells by methotrexate synchronization and thymidine release. Cancer Genet Cytogenet 1985; 14:275-84; PMID:3967208; http://dx.doi.org/10.1016/0165-4608(85)90193-1
   PubMed Web of Science ®Google Scholar
• Moran RE, Straus MJ. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy. Cancer Treat Rep 1980; 64:81-6; PMID:7379059
   PubMedGoogle Scholar
• Dethlefsen LA, Sorensen SP, Riley RM. Effects of double and multiple doses of hydroxyurea on mouse duodenum and mammary tumors. Cancer Res 1975; 35:694-9; PMID:1116130
   PubMed Web of Science ®Google Scholar
• Finzi L, Kraemer A, Capron C, Noullet S, Goere D, Penna C, Nordlinger B, Legagneux J, Emile JF, Malafosse R. Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate. J Exp Clin Cancer Res 2011; 30:92; PMID:21970612
   PubMed Web of Science ®Google Scholar
• Keir ST, Friedman HS, Reardon DA, Bigner DD, Gray LA. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model. J Neurooncol 2013; 111:97-102; PMID:23086436; http://dx.doi.org/10.1007/s11060-012-0995-0
   PubMed Web of Science ®Google Scholar
• Keyomarsi K, Sandoval L, Band V, Pardee AB. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 1991; 51:3602-9; PMID:1711413
   PubMed Web of Science ®Google Scholar
• Javanmoghadam-Kamrani S, Keyomarsi K. Synchronization of the cell cycle using lovastatin. Cell Cycle 2008; 7:2434-40; PMID:18677105; http://dx.doi.org/10.4161/cc.6364
   PubMed Web of Science ®Google Scholar
• Huang X, Di Liberto M, Jayabalan D, Liang J, Ely S, Bretz J, Shaffer AL 3rd, Louie T, Chen I, Randolph S, et al. Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4. Blood 2012; 120:1095-106; PMID:22718837; http://dx.doi.org/10.1182/blood-2012-03-415984
   PubMed Web of Science ®Google Scholar
• Vassilev LT. Cell cycle synchronization at the G2/M phase border by reversible inhibition of CDK1. Cell Cycle 2006; 5:2555-6; PMID:17172841; http://dx.doi.org/10.4161/cc.5.22.3463
   PubMed Web of Science ®Google Scholar
• Dong XF, Berthois Y, Dussert C, Isnardon D, Palmari J, Martin PM. Mode of EGF action on cell cycle kinetics in human breast cancer cell line MCF-7: some evidence that EGF acts as a “progression factor”. Anticancer Res 1992; 12:2085-92; PMID:1295452
   PubMed Web of Science ®Google Scholar
• Hambek M, Werner C, Baghi M, Gstöttner W, Knecht R. Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation. Eur J Cancer 2007; 43:1502-7; PMID:17524637; http://dx.doi.org/10.1016/j.ejca.2005.09.037
   PubMed Web of Science ®Google Scholar
• Hambek M, Werner C, Baghi M, Gstöttner W, Knecht R. Prestimulation of head and neck cancer cells with growth factors enhances treatment efficacy. Anticancer Res 2006; 26:1091-5; PMID:16619511
   PubMed Web of Science ®Google Scholar
• Grdina DJ, Meistrich ML, Meyn RE. Cell synchrony techniques. A comparison of methods. In: Techniques in Cell Cycle Analysis. Gray JW and Darzynkiewicz A (eds). Humana Press Inc., Clifton, NJ, 1987; 367-403.
   Google Scholar
• Davis PK, Ho A, Dowdy SF. Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques 2001; 30:1322-6, 1328, 1330-1.
   PubMed Web of Science ®Google Scholar
• Merril GF. Cell synchronization. Methods Cell Biol 1998; 57:229-249; PMID:9648108; http://dx.doi.org/10.1016/S0091-679X(08)61582-4
   PubMed Web of Science ®Google Scholar
• Amon A. Synchronization procedures. Methods Enzymol 2002; 351:457-67; PMID:12073363; http://dx.doi.org/10.1016/S0076-6879(02)51864-4
   PubMed Web of Science ®Google Scholar
• Hoffman RM. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis: a review and synthesis. Biochim Biophys Acta Reviews on Cancer 1984; 738:49-87; http://dx.doi.org/10.1016/0304-419X(84)90019-2
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Erbe RW. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci USA 1976; 73:1523-7; PMID:179090; http://dx.doi.org/10.1073/pnas.73.5.1523
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Jacobsen SJ, Erbe RW. Reversion to methionine independence by malignant rat and SV40-transformed human fibroblasts. Biochem Biophys Res Commun 1978; 82:228-34; PMID:208554; http://dx.doi.org/10.1016/0006-291X(78)90600-9
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Jacobsen SJ, Erbe RW. Reversion to methionine independence in simian virus 40-transformed human and malignant rat fibroblasts is associated with altered ploidy and altered properties of transformation. Proc NatlAcad Sci USA 1979; 76:1313-7; http://dx.doi.org/10.1073/pnas.76.3.1313
   PubMed Web of Science ®Google Scholar
• Coalson DW, Mecham JO, Stem PH, Hoffman RM. Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells. Proc Natl Acad Sci USA 1982; 79:4248-51; PMID:6289297; http://dx.doi.org/10.1073/pnas.79.14.4248
   PubMed Web of Science ®Google Scholar
• Stem PH, Mecham JO, Wallace CD, Hoffman RM. Reduced free-methionine in methionine-dependent SV40-transformed human fibroblasts synthesizing apparently normal amounts of methionine. J Cell Physiol l983; 117:9-14.
   PubMed Web of Science ®Google Scholar
• Mecham JO, Rowitch D, Wallace CD, Stem PH, Hoffman RM. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 1983; 117:429-34; PMID:6661235; http://dx.doi.org/10.1016/0006-291X(83)91218-4
   PubMed Web of Science ®Google Scholar
• Stem PH, Wallace CD, Hoffman RM. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol 1984; 9:29-34.
   Google Scholar
• Stem PH, Hoffman RM. Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro 1984; 20:663-70; PMID:6500606; http://dx.doi.org/10.1007/BF02619617
   PubMedGoogle Scholar
• Tan Y, Xu M, Tan X-Z, Tan X-Y, Wang, X, Saikawa Y, Nagahama T, Sun X, Lenz M, Hoffman RM. Overexpression and large-scale production of recombinant l-methionine-a-deamino-g-mercaptomethane-lyase for novel anticancer therapy. Prot Exp Purif 1997; 9:233-45; http://dx.doi.org/10.1006/prep.1996.0700
   PubMed Web of Science ®Google Scholar
• Uchugonova A, Duong J, Zhang N, König K, Hoffman RM. The bulge area is the origin of nestin-expressing pluripotent stem cells of the hair follicle. J Cell Biochem 2011; 112:2046-50; PMID:21465525; http://dx.doi.org/10.1002/jcb.23122
   PubMed Web of Science ®Google Scholar